Byers Capital is as a family office with a focus on early stage technology investing.

Announced investments include:

• Neuralink (Series B) 

• NewLimit (Cofounded)

• Culdesac (Series A)

• Vial (Series A)

• Benchling (Growth)

• Freenome (Growth)

• Grail (Series A)